Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 26, 2020	Dec. 28, 2019
Restricted Cash	$ 6,758	$ 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 1,803,719	1,720,194
Document Period End Date	Dec. 26, 2020
Other Operating Activities, Cash Flow Statement	$ (647)	(5,961)
Stock or Unit Option Plan Expense	18,498	18,535
Net income	353,459	286,206
Proceeds from sale of available-for-sale securities	1,500	0
Cash flows from operating activities:
Net income	353,459	286,206
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	66,939	48,738
Depreciation and amortization	48,340	48,008
Deferred taxes	(2,885)	(2,231)
Gain (Loss) on Disposition of Property Plant Equipment	227	489
Changes in assets and liabilities:
Accounts receivable	(81,199)	11,674
Inventories	(1,944)	22,583
Other assets	(5,709)	(55,820)
Accounts payable	5,522	4,844
Price adjustment and other revenue reserves	31,503	4,747
Income taxes payable	(31,118)	(31,133)
All other accrued liabilities	(10,772)	34,669
Net cash provided by (used in) operating activities	373,010	378,735
Cash flows from investing activities:
Purchases of property, plant and equipment	(29,213)	(34,301)
Proceeds from sale of property, plant and equipment	67	171
Proceeds from sale of available-for-sale securities	1,500	0
Proceeds from maturity of available-for-sale securities	25,025	78,067
Purchases of investments in privately-held companies	(110)	0
Proceeds from Sale of Other Assets, Investing Activities	39	0
Other investing activities	0	(68)
Net cash provided by (used in) investing activities	(2,692)	43,869
Cash flows from financing activities:
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset	0	(8,000)
Payments of Stock Issuance Costs	(35,984)	(17,566)
Proceeds from Stock Options Exercised	2,807	8,820
Stock or Unit Option Plan Expense	18,498	18,535
Repurchase of common stock	(9,201)	(201,509)
Payments of Dividends	(128,147)	(260,032)
Net cash provided by (used in) financing activities	(152,027)	(459,752)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	218,291	(37,148)
Cash and cash equivalents:
Cash paid (refunded), net during the period for income taxes	81,464	63,692
Interest Paid, Excluding Capitalized Interest, Operating Activities		17,063
Noncash investing and financing activities:
Accounts payable related to property, plant, and equipment purchases	11,041	$ 12,360
Cash and Cash Equivalents, at Carrying Value	$ 1,796,961